RBC Capital Maintains Outperform on Acadia Healthcare Co, Lowers Price Target to $94
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Ben Hendrix has maintained an 'Outperform' rating on Acadia Healthcare Co (NASDAQ:ACHC) but lowered the price target from $99 to $94.
November 07, 2023 | 6:06 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Acadia Healthcare's price target has been lowered by RBC Capital from $99 to $94, though the 'Outperform' rating is maintained.
The news is directly about Acadia Healthcare Co. The lowering of the price target might indicate a potential downside, but the maintained 'Outperform' rating suggests that the analyst still sees the company as a good investment. This could lead to mixed reactions in the market, hence the neutral score.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100